Overall survival was significantly better with the combination therapy, achieving 23.1 months versus 19.6 months with PHP alone. Combination therapy of percutaneous hepatic perfusion with immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback